These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26556413)

  • 1. Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.
    López-Cabrera M
    Adv Med; 2014; 2014():473134. PubMed ID: 26556413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can we do to preserve the peritoneum?
    Krediet RT; Zweers MM; van Westrhenen R; Ho-dac-Pannekeet MM; Struijk DG
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S14-9. PubMed ID: 17986535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies.
    del Peso G; Jiménez-Heffernan JA; Selgas R; Remón C; Ossorio M; Fernández-Perpén A; Sánchez-Tomero JA; Cirugeda A; de Sousa E; Sandoval P; Díaz R; López-Cabrera M; Bajo MA
    Perit Dial Int; 2016; 36(2):129-34. PubMed ID: 26475848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats.
    Ikehara O; Nishimura H; Naito T; Higuchi C; Sanaka T
    Nephron Exp Nephrol; 2005; 100(1):e30-9. PubMed ID: 15731567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
    Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
    Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
    Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
    J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid.
    Kopytina V; Pascual-Antón L; Toggweiler N; Arriero-País EM; Strahl L; Albar-Vizcaíno P; Sucunza D; Vaquero JJ; Steppan S; Piecha D; López-Cabrera M; González-Mateo GT
    Front Pharmacol; 2022; 13():868374. PubMed ID: 36052133
    [No Abstract]   [Full Text] [Related]  

  • 12. Solutions for APD: special considerations.
    Passlick-Deetjen J; Schaub TP; Schilling H
    Semin Dial; 2002; 15(6):407-13. PubMed ID: 12437535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which future solutions for peritoneal dialysis?].
    Bonomini M; Di Liberato L; Rago C; Lombardi T; Sirolli V; Arduini A
    G Ital Nefrol; 2021 Oct; 38(5):. PubMed ID: 34713640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do low GDP neutral pH solutions prevent or retard peritoneal membrane alterations in long-term peritoneal dialysis?
    Parikova A; Michalickova K; van Diepen AT; Voska L; Viklicky O; Krediet RT
    Perit Dial Int; 2022 May; 42(3):236-245. PubMed ID: 34259088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
    Fusshoeller A
    Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.
    Marchant V; Tejera-Muñoz A; Marquez-Expósito L; Rayego-Mateos S; Rodrigues-Diez RR; Tejedor L; Santos-Sanchez L; Egido J; Ortiz A; Valdivielso JM; Fraser DJ; López-Cabrera M; Selgas R; Ruiz-Ortega M
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Membrane Preservation.
    Bajo MA; Del Peso G; Teitelbaum I
    Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.
    Bartosova M; Schaefer B; Vondrak K; Sallay P; Taylan C; Cerkauskiene R; Dzierzega M; Milosevski-Lomic G; Büscher R; Zaloszyc A; Romero P; Lasitschka F; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Front Physiol; 2019; 10():356. PubMed ID: 31001140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
    Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
    J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.